ZellBios gets new loan and private equity owner

ZellBios, which makes pharmaceutical ingredients, is raising €125m of drawn and undrawn debt to finance its buyout by Deutsche Private Equity.

  • By Olivier Holmey
  • 18 Dec 2013

The company, born of the 2011 merger of Italy’s Farmabios and Germany’s Pharmazell, previously belonged to Ergon Capital.

The all-senior buyout debt consists of a €33m term loan ‘A’, €67m term loan ‘B’, €15m revolver and €10m capex facility. The term loan ‘B’ is priced at 450bp over ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
1 BNP Paribas 15,256 32 17.31
2 Bank of America Merrill Lynch (BAML) 9,637 29 10.93
3 Citi 8,264 22 9.37
4 Lloyds Bank 7,329 24 8.31
5 JP Morgan 6,580 10 7.46

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 130,010.09 379 11.12%
2 Bank of America Merrill Lynch 104,113.90 304 8.90%
3 JPMorgan 102,778.33 300 8.79%
4 Wells Fargo Securities 93,728.92 276 8.01%
5 Credit Suisse 76,904.09 209 6.58%